Advanced / metastatic solid tumor
Clinical trials for Advanced / metastatic solid tumor explained in plain language.
Never miss a new study
Get alerted when new Advanced / metastatic solid tumor trials appear
Sign up with your email to follow new studies for Advanced / metastatic solid tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancer: experimental drug DB-1419 enters human trials
Disease control Recruiting nowThis study tests a new experimental drug, DB-1419, in adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 360 participants will ta…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase 1/2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New radioactive drug shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new radioactive drug (BRP-020063) in 10 people with advanced solid tumors that have spread. The drug is used first for imaging to find tumors, then a low dose is given to see if it's safe and how it travels in the body. The goal is to gather informa…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Early phase 1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New mRNA vaccine takes on tough cancers
Disease control Recruiting nowThis early-stage trial tests a new mRNA vaccine called ABO2102, designed to target cancers with specific KRAS mutations. About 101 adults with advanced solid tumors will receive the vaccine alone or with another drug (Sintilimab). The study focuses on safety and how the body resp…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase 1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cancer drug MBRC-101 enters human trials for Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase trial is testing MBRC-101, a drug that seeks out cancer cells and delivers a chemotherapy payload directly to them. It is for people with advanced solid tumors that have not responded to standard treatments. The study will first find the safest dose, then check f…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase 1/2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Morning or afternoon? new study tests best time for immunotherapy
Knowledge-focused Recruiting nowThis study looks at whether getting immunotherapy in the morning or afternoon changes how well it works for people with advanced lung cancer. About 350 patients will be randomly assigned to receive their treatment either before 11 AM or after 12 PM. The goal is to see if timing a…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase 2 • Sponsor: Liza Villaruz, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC